Yashwant Pathak
- Pharmaceutical Science top 1%
- Drug Solubulity and Delivery Systems 11
- Advanced Drug Delivery Systems 10
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 12
- Oncology top 5%
- CAR-T cell therapy research 5
- Immunology top 10%
- Ophthalmology top 5%
-
- Computational Drug Discovery Methods 7
-
- Graphene and Nanomaterials Applications 5
- Nanoplatforms for cancer theranostics 5
-
- Corneal Surgery and Treatments 5
- Co-authors
- Vijaykumar SutariyaA. K. DorleFaroogh MarofiAnjali HiraniMax Stanley ChartrandNavid ShomaliMostafa JarahianSafa Tahmasebi
- Partner nations
- United StatesIndonesiaIndia
In The Last Decade
Yashwant Pathak
105 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Pharmaceutical Science 316
- Biomaterials 283
- Oncology 470
- Immunology 272
- Ophthalmology 80
Countries citing papers authored by Yashwant Pathak
This map shows the geographic impact of Yashwant Pathak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yashwant Pathak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yashwant Pathak more than expected).
Fields of papers citing papers by Yashwant Pathak
This network shows the impact of papers produced by Yashwant Pathak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yashwant Pathak. The network helps show where Yashwant Pathak may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yashwant Pathak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 3 | |
| 11 | 2022 | 13 | |
| 12 | 2022 | 5 | |
| 13 | 2022 | 1 | |
| 14 | 2022 | 10 | |
| 15 | 2021 | 18 | |
| 16 | 2019 | 11 | |
| 17 | Stem cell nano drug delivery applications to treat diabetes | 2016 | 1 |
| 18 | 2015 | 3 | |
| 19 | Morphological Characterization of Maltodextrin Derivatives Using Scanning Electron Microscopy | 1993 | 4 |
| 20 | Scanning Electron Microscopy Studies of the Prevention of Bioprosthetic Heart Valve Calcification With Controlled Release Polymeric Matrices | 1991 | 3 |
About Yashwant Pathak
Yashwant Pathak is a scholar working on Pharmaceutical Science, Biomaterials and Health Informatics, having authored 114 papers that have together received 1.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (12 papers), Drug Solubulity and Delivery Systems (11 papers), Advanced Drug Delivery Systems (10 papers), Computational Drug Discovery Methods (7 papers), Graphene and Nanomaterials Applications (5 papers), Nanoplatforms for cancer theranostics (5 papers), Corneal Surgery and Treatments (5 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Pharmaceutical Science (316 citations), Biomaterials (283 citations) and Oncology (470 citations). Yashwant Pathak has collaborated with scholars based in United States, Indonesia and India. Frequent co-authors include Vijaykumar Sutariya, A. K. Dorle, Faroogh Marofi, Anjali Hirani, Max Stanley Chartrand, Navid Shomali, Mostafa Jarahian, Safa Tahmasebi, Farhad Motavalli Khiavi and Alexei Valerievich Yumashev.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.